SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-039633
Filing Date
2021-08-02
Accepted
2021-08-02 07:00:51
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20210630.htm   iXBRL 10-Q 1262170
2 EX-31.1 nerv-ex311_8.htm EX-31.1 20624
3 EX-31.2 nerv-ex312_7.htm EX-31.2 20199
4 EX-32.1 nerv-ex321_10.htm EX-32.1 9906
  Complete submission text file 0001564590-21-039633.txt   5161261

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nerv-20210630.xsd EX-101.SCH 39435
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20210630_cal.xml EX-101.CAL 37788
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20210630_def.xml EX-101.DEF 122660
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20210630_lab.xml EX-101.LAB 316921
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20210630_pre.xml EX-101.PRE 246492
10 EXTRACTED XBRL INSTANCE DOCUMENT nerv-10q_20210630_htm.xml XML 880005
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 211134712
SIC: 2834 Pharmaceutical Preparations